Advertisement

Preventive Strategies in Radiation-Associated Dysphagia

  • Debnarayan Dutta
  • Krishnakumar Thankappan
Chapter

Abstract

Definitive radical radiotherapy (RT) or concurrent chemoradiotherapy (CRT) is the contemporary standard of care in the nonsurgical management of head and neck squamous cell carcinoma (HNSCC) treated with curative intent. This has shown significant improvements in outcome in certain subsites [1, 2]. The swallowing mechanism can be affected by radiation therapy, resulting in major impairment of swallowing form and function [3, 4]. Although concurrent CRT improves tumor control, it is associated with high rates of severe early and late mucosal and laryngopharyngeal toxicity resulting in more incidence and severity of swallowing-related problems, like dysphagia, aspiration, weight loss, and feeding tube dependence. The present chapter will focus on the preventive aspects of dysphagia associated with head and neck cancers treated with RT or CRT.

References

  1. 1.
    Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer. Lancet. 2000;355:949–55.CrossRefGoogle Scholar
  2. 2.
    Pignon JP, Le Maitre A, Maillard E, Bourhis J, MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update of 93 trials and 17, 346 patients. Radiother Oncol. 2009;92:4–14.CrossRefGoogle Scholar
  3. 3.
    Gillespie MB, Brodsky MB, Day TA, Lee FS, Martin-Harris B. Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope. 2004;14:1362–7.CrossRefGoogle Scholar
  4. 4.
    Frowen J, Perry A. Swallowing outcomes after radiotherapy for head and neck cancer: a systematic review. Head Neck. 2006;28:932–44.CrossRefGoogle Scholar
  5. 5.
    Hutcheson KA. Rehabilitation of heavily treated head and neck cancer patients. In: Bernier J, editor. Head and neck cancer multimodality management. 2nd ed. Basel: Springer; 2016. p. 787–8.Google Scholar
  6. 6.
    Pauloski BR. Rehabilitation of dysphagia following head and neck cancer. Phys Med Rehabil Clin N Am. 2008;19:889–928.CrossRefGoogle Scholar
  7. 7.
    Nguyen NP, Vos P, Smith HJ, et al. Concurrent chemoradiation for locally advanced Oropharyngeal cancer. Am J Otolaryngol. 2007;28:3–8.CrossRefGoogle Scholar
  8. 8.
    Nguyen NP, Moltz CC, Frank C, et al. Evolution of chronic dysphagia following treatment for head and neck cancer. Oral Oncol. 2006;42:374–80.CrossRefGoogle Scholar
  9. 9.
    Goguen LA, Posner M, Norris CM, et al. Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Otolaryngol Head Neck Surg. 2006;134:916–22.CrossRefGoogle Scholar
  10. 10.
    Lee WT, Akst LM, Adelstein DJ, et al. Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent Chemoradiation. Head Neck. 2006;28:808–12.CrossRefGoogle Scholar
  11. 11.
    Sullivan CA, Jaklitsch MT, Haddad R, et al. Endoscopic management of hypopharyngeal stenosis after organ sparing therapy for head and neck cancer. Laryngoscope. 2004;114:1924–31.CrossRefGoogle Scholar
  12. 12.
    Franzmann EJ, Lundy DS, Abitbol AA, et al. Complete hypopharyngeal obstruction by mucosal adhesions: a complication of intensive chemoradiation for advanced head and neck cancer. Head Neck. 2006;28:663–70.CrossRefGoogle Scholar
  13. 13.
    Mekhail TM, Adelstein DJ, Rybicki LA, et al. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube? Cancer. 2001;91:1785–90.CrossRefGoogle Scholar
  14. 14.
    Mortensen HR, Overgaard J, Jensen K, et al. Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiation therapy for head and neck cancer. Acta Oncol. 2013;52:1535–42.CrossRefGoogle Scholar
  15. 15.
    Agarwal JP, Dutta D, Palwe V, et al. Prospective subjective evaluation of swallowing function and dietary pattern in head and neck cancers treated with concomitant chemoradiation. J Cancer Res Ther. 2010;6(1):15–21.CrossRefGoogle Scholar
  16. 16.
    Agarwal JP, Palwe V, Dutta D, et al. Objective assessment of swallowing function after definitive (chemo)radiation therapy in patients with head and neck cancer. Dysphagia. 2011;26(4):399–406.CrossRefGoogle Scholar
  17. 17.
    Ursino S, D'Angelo E, Mazzola R, et al. A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy: a systematic review by the Italian Head and Neck Radiotherapy Study Group. Strahlenther Onkol. 2017;193(11):877–89.  https://doi.org/10.1007/s00066-017-1160-7.CrossRefPubMedGoogle Scholar
  18. 18.
    Francis DO, Weymuller EA Jr, Parvathaneni U, Merati AL, Yueh B. Dysphagia, stricture, and pneumonia in head and neck cancer: does treatment modality matter? Ann Otol Rhinol Laryngol. 2010;119:391–7.CrossRefGoogle Scholar
  19. 19.
    Langendijk JA, Doornaert P, Rietveld DH, Verdonck-de Leeuw IM, Leemans CR, Slotman BJ. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol. 2009;90:189–95.CrossRefGoogle Scholar
  20. 20.
    Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys. 2004;60(5):1425–39.CrossRefGoogle Scholar
  21. 21.
    Levendag PC, Teguh DN, Voet P, van der Est H, Noever I, de Kruijf WJ, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol. 2007;85(1):64–73.CrossRefGoogle Scholar
  22. 22.
    Caglar HB, Tishler RB, Othus M, Burke E, Li Y, Goguen L, et al. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72(4):1110–8.CrossRefGoogle Scholar
  23. 23.
    Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50(3):695–704.CrossRefGoogle Scholar
  24. 24.
    Eisbruch A, Levendag PC, Feng FY, Teguh D, Lyden T, Schmitz PI, et al. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S40–2.CrossRefGoogle Scholar
  25. 25.
    Feng FY, Kim HM, Lyden TH, Haxer MJ, Feng M, Worden FP, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2007;68(5):1289–98.CrossRefGoogle Scholar
  26. 26.
    Jensen K, Lambertsen K, Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiother Oncol. 2007;85(1):74–82.CrossRefGoogle Scholar
  27. 27.
    Eisbruch A. Radiotherapy: IMRT reduces xerostomia and potentially improves QoL. Nat Rev Clin Oncol. 2009;6:567–8.CrossRefGoogle Scholar
  28. 28.
    Eisbruch A, Lyden T, Bradford CR, Dawson LA, Haxer MJ, Miller AE, Teknos TN, Chepeha DB, Hogikyan ND, Terrell JE, Wolf GT. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2002;53:23–8.CrossRefGoogle Scholar
  29. 29.
    Bussels B, Maes A, Hermans R, Nuyts S, Weltens C, den V, Bogaert W. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol. 2004;72:119–27.CrossRefGoogle Scholar
  30. 30.
    Bussels B, Hermans R, Reijnders A, Dirix P, Nuyts S, den V, Bogaert W. Retropharyngeal nodes in squamous cell carcinoma of oropharynx: incidence, localization, and implications for target volume. Int J Radiat Oncol Biol Phys. 2006;65:733–8.CrossRefGoogle Scholar
  31. 31.
    Eisbruch A, Marsh LH, Dawson LA, Bradford CR, Teknos TN, Chepeha DB, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys. 2004;59(1):28–42.CrossRefGoogle Scholar
  32. 32.
    Platteaux N, Dirix P, Dejaeger E, Nuyts S. Dysphagia in head and neck cancer patients treated with chemoradiotherapy. Dysphagia. 2010 Jun;25(2):139–52.CrossRefGoogle Scholar
  33. 33.
    Logemann JA, Pauloski BR, Rademaker AW, et al. Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck. 2003;25(6):432–7.CrossRefGoogle Scholar
  34. 34.
    Chao KS, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys. 2001;49:907–16.CrossRefGoogle Scholar
  35. 35.
    Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45:577–87.CrossRefGoogle Scholar
  36. 36.
    Nutting CM, Morden JP, Harrington KJ, et al. PARSPORT trial management group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12:127–36.CrossRefGoogle Scholar
  37. 37.
    Paleri V, Roe JW, Strojan P, et al. Strategies to reduce long-term post chemoradiation dysphagia in patients with head and neck cancer: an evidence-based review. Head Neck. 2014;36:431–43.CrossRefGoogle Scholar
  38. 38.
    Arrese LC, Lazarus CL. Special groups: head and neck cancer. Otolaryngol Clin N Am. 2013;46:1123–36.CrossRefGoogle Scholar
  39. 39.
    Van der Molen L, van Rossum MA, Burkhead LM, et al. A randomized preventive rehabilitation trial in advanced head and neck cancer patients treated with chemoradiotherapy: feasibility, compliance, and short-term effects. Dysphagia. 2011;26:155–70.CrossRefGoogle Scholar
  40. 40.
    Carnaby-Mann G, Crary MA, Schmalfuss I, et al. “Pharyngocise”: randomized controlled trial of preventative exercises to maintain muscle structure and swallowing function during head-and-neck chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012;83:210–9.CrossRefGoogle Scholar
  41. 41.
    Kulbersh BD, Rosenthal EL, McGrew BM, et al. Pretreatment, preoperative swallowing exercises may improve dysphagia quality of life. Laryngoscope. 2006;116:883–6.CrossRefGoogle Scholar
  42. 42.
    Carroll WR, Locher JL, Canon CL, et al. Pretreatment swallowing exercises improve swallow function after chemoradiation. Laryngoscope. 2008;118:39–43.CrossRefGoogle Scholar
  43. 43.
    Kotz T, Federman AD, Kao J, et al. Prophylactic swallowing exercises in patients with head and neck cancer undergoing chemoradiation: a randomized trial. Arch Otolaryngol Head Neck Surg. 2012;138(4):376–82.CrossRefGoogle Scholar
  44. 44.
    Ahlberg A, Engstrom T, Nikolaidis P, et al. Early self-care rehabilitation of head and neck cancer patients. Acta Otolaryngol. 2011;131:552–61.CrossRefGoogle Scholar
  45. 45.
    Carnaby G, Lagorio L, Crary M, Amdur R, Schmalfuss I. Dysphagia prevention exercises in head and neck cancer: Pharyngocise dose response study. In: Proceedings of the 20th Annual Meeting of the Dysphagia Research Society, March 8–10, 2012. Toronto, Ontario, Canada; 2012.Google Scholar
  46. 46.
    Paleri V, Patterson J. Use of gastrostomy in head and neck cancer: a systematic review to identify areas for future research. Clin Otolaryngol Allied Sci. 2010;35:177–89.CrossRefGoogle Scholar
  47. 47.
    Oozeer NB, Corsar K, Glore RJ, Penney S, Patterson J, Paleri V. The impact of enteral feeding route on patient-reported long term swallowing outcome after chemoradiation for head and neck cancer. Oral Oncol. 2011;47:980–3.CrossRefGoogle Scholar
  48. 48.
    Chen AM, Li BQ, Lau DH, et al. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2010;78:1026–32.CrossRefGoogle Scholar
  49. 49.
    Corry J, Poon W, McPhee N, et al. Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation. Head Neck. 2009;31:867–76.CrossRefGoogle Scholar
  50. 50.
    Corry J, Poon W, McPhee N, et al. Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiation. J Med Imaging Radiat Oncol. 2008;52:503–10.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  1. 1.Department of Radiation OncologyAmrita Institute of Medical Sciences, Amrita Vishwa VidyapeethamKochiIndia
  2. 2.Department of Head and Neck Surgery and OncologyAmrita Institute of Medical Sciences, Amrita Vishwa VidyapeethamKochiIndia

Personalised recommendations